Due to the increasing number of nosocomial infections and multidrug-resistant bacterial strains, Staphylococcus aureus is now a major worldwide concern. Rapid detection and characterization of this bacterium has become an important issue for biomedical applications. Biosensors are increasingly appearing as low-cost, easy-to-operate and fast alternatives for rapid detection. In this review, we will introduce the main characteristics of S. aureus and will focus on the interest of biosensors for a faster detection of whole S. aureus cells. In particular, we will review the most promising strategies in the choice of ligand for the design of selective and efficient biosensors. Their specific characteristics as well as their advantages and/or disadvantages will also be commented.
Introduction
Staphylococcus aureus (SA) is a human commensal bacterium found in almost one-third of the human population. Another third of the population is occasionally colonized by this bacterium. The anterior nares are the main ecological niche of SA in the human body (Wertheim et al. 2005) . Unfortunately, this commensal bacterium can become a dangerous opportunistic pathogen. As an example, a clear correlation between nasal carriage and SA bacteraemia (SAB) has been observed, as 80% of the strains causing bacteraemia in carriers are endogenous (Wertheim et al. 2004) . In several countries, this observation has prompted systematic pre-admission screening of SA carriage, especially that of methicillinresistant S. aureus (MRSA) prior to the admission in hospital settings where the population is at risk of developing SAB (Verhoeven et al. 2014) . Among the human bacterial pathogens, very few cause such a wide variety of infections as SA (Tong et al. 2015) . Due to both an elevated incidence and an associated mortality ranging from 10 to 30%, SAB is a major subject of concern (Tong et al. 2015) . Without suitable antibiotic therapy, this infection may lead to sepsis, a condition which aggravates the prognosis and necessitates immediate care. Administering the proper antibiotic requires bacterial identification and antibiotic susceptibility testing. This profiling is of considerable importance for bacteria such as SA in which almost 20% of the isolates are now resistant to methicillin antibiotic family (Le Moing et al. 2015) . In a global context with multidrug-resistant pathogens on the rise, it is especially important to limit the use of second-line antibiotics. Bacterial identification therefore must be as quick as possible, ideally at the point of care. Biosensors have shown to satisfy these stringent requirements.
As many papers focusing on the SA enterotoxins detection can be found in the literature, we do not dwell on that topic. Rather, our review includes papers dealing with whole-SA cell detection whose presence can indicate contamination of patient or food products and possibly the production of enterotoxins. A brief discussion of several SA-specific properties contributing to its pathogenicity seems necessary as some of them might interfere with its proper detection. Firstly, the well-known staphylococcal protein A is a perfect example of SA surface proteins that can lead to false-positive results when immunoglobulins are used as ligands. Indeed, as shown in Table 1 , protein A has affinity for most of the antibodies commonly used in immunoassays. But, above all, this protein A contributes to SA escape from antibodymediated opsonophagocytosis. In antibody-containing environments such as blood, circulating antibodies are bound to the SA surface by their Fc region instead of being fixed to an antigen by their Fab regions. This abnormal orientation prevents the recognition of SA by immune cell receptors and thus phagocytosis. In addition to these immunoglobulin-binding properties, protein A promotes biofilm formation in liquid media (Merino et al. 2009 ) which can be problematic for biosensors.
Secondly, another property which distinguishes SA from other staphylococci is the ability to clot blood. SA possesses two coagulases, Coa and vWbp (von Willebrand factor binding protein). Both contribute to SA pathogenicity, by taking part in abscess formation (Cheng et al. 2010) . They mediate the conversion of soluble fibrinogen into insoluble fibrin which then forms a protective capsule around individual SA cells and cell aggregates. Several surface proteins, including the clumping factor A, attract fibrinogen near SA surface which becomes hardly accessible to immune effectors such as antibodies (Thammavongsa et al. 2015) . This mechanism protects SA from opsonophagocytosis, as the polysaccharide capsule does in the absence of specific antibodies, by hindering bacterial surface proteins (O'Riordan and Lee 2004) .
Finally, another issue to consider when trying to detect SA is the presence of specific antibodies in biological fluids such as milk or blood. For example, among the 67 to 80 lmol l À1 of IgG present in human blood (corresponding to 10-12 g l À1 ), between 0Á1 and 3% of the total IgG can be specific of SA epitopes (Dryla et al. 2005) . Due to the omnipresence of SA in our environment, SA exposure is unavoidable and leads to the production of these antibodies, which are then maintained for years (Verkaik et al. 2009; Colque-Navarro et al. 2010) . As demonstrated by Wheat et al. (1979) , the presence of SA-specific antibodies in a serum is usually associated with an increase in the limit of detection (LOD) of staphylococcal antigens by immunoassay. Such results demonstrate the potential competition occurring between specific circulating antibodies and those used for SA detection with immunoassay-based sensors.
Whole-cell detection with biosensors dedicated to S. aureus
Whole-cell detection on biosensors
Most methods used so far for the detection of bacterial pathogens rely on microbial culture on selective or chromogenic media , ELISA immunoassays (Yazdankhah et al. 1998) , selective gene amplification and detection (Tombelli et al. 2006) or indirect detection of metabolites such as toxins (Yang et al. 2010) . Although quite sensitive, these methods require several processing steps such as cell preculture and liquid enrichment, bacterial lysis and DNA purification and amplification, as well as a large number of costly reagents, dedicated instruments and skilled operators. Routine analysis of clinical samples may take up to a week to obtain a result. This long processing time is a critical issue as patients infected by SA require fast and efficient antibiotic therapy to control and neutralize the infection. Such limitations strengthen the interest in proposing alternative methods facing the specific challenges of bacterial pathogen detection and justify the increasing interest of biosensors for such applications. Indeed, biosensors may display several characteristics facing such challenges including miniaturized format, and thus reduced sample and reagent volumes, along with the possible use as point-of-care devices. Another important feature is the possible direct sample processing based on whole-cell detection (Ahmed et al. 2014) . This search for intact bacterial cells reduces the time-toresult delay and guides the physician in a faster choice for the proper antibiotic treatment depending on the identified pathogen. This point is particularly important for SA as the screening for super-resistant strains (methicillin-resistant) is systematically performed in patients before their hospitalization in some countries (Vos et al. 2009 ). Biosensors are composed of a sensing probe, also named ligand, physically linked to a transducing element, which fires a signal when a target binds to the probe (Templier et al. 2016) . The transducer then produces an electrical, electrochemical, optical or mechanical response depending on the biosensor design (Ahmed et al. 2014) . Besides the strategy chosen for signal processing, the choice of the ligand enabling whole-bacterial cell capture on the biosensor is also an important issue. Indeed, the ligand efficiency determines the whole assay performance, as the probe ensures the target specificity (true-negative rate) vs assay sensitivity (true-positive rate). With the aim of designing efficient biosensors enabling the native whole-SA detection, several types of ligands have been described in the literature (Fig. 1 ).
Bacteriophages
Bacteriophages are viruses specific to bacteria. Because they are highly abundant on Earth, with total population estimated c. 10 32 entities (Kutter et al. 2004) , they are strongly involved in bacterial species regulation. Bacteriophages can be classified depending on the nature of their genomic material-either DNA or RNA; on their shape; on the presence or absence of tail on the viral nucleocapsid or envelop around the capsid; or on their action mode. Bacteriophages are usually highly specific to subsets of bacteria, which makes them attractive as probes for specific bacterial pathogen detection on biosensors.
Although their isolation and purification requires timeconsuming steps, their ability to quickly multiply during infection gives access to large numbers of viral particles, which can be used as nanometric probes for bacterial detection on biosensing devices. For instance, the simple adsorption of phage 12600 on microscope slides enabled the label-free capture of SA cells suspended in pure water (Guntupalli et al. 2008) . The direct slide observation under a microscope confirmed the specific capture of this bacterium, while almost no capture of Salmonella enterica serovar Typhimurium nor Bacillus subtilis was detected. Although the LOD is still quite high (10 8 -10 9 CFU per ml), and thus requires blood culture to increase the bacterial concentration in the sample before running the analysis, this easy-to-operate approach paves the way to more competitive approaches than the ones that are currently used. Label-free detection methods based on surface plasmon resonance (SPR) may also be used for the identification of SA present in PBS samples (Balasubramanian et al. 2007) . In Balasubramanian's work, the authors decreased the LOD down to 10 4 CFU per ml with the same bacteriophage (phage 12600) used as the probe grafted on a biosensor. Specificity experiments led with another serovar of Salmonella (Salmonella enterica serovar Enteritidis), closely related to the Salmonella enterica serovar Typhimurium strain tested by others (Guntupalli et al. 2008) , confirmed the specificity of this phage towards SA as S. Enteritidis could not be detected. The choice of competing bacterial pathogens to assess the phage specificity in such assay is important. Indeed, distantly related bacteria (from different genus or species) may share only few common recognition motifs with the target bacterium, and thus may show only weak crossreactivity in the presence of the same phage. Specificity assays carried out with closely related bacteria turn out to be challenging. In the specific case of SA, one of the most important issues in the characterization of this bacterium is the distinction between MRSA and methicillin-sensitive SA (MSSA) strains. Biosensors capable of such specificity have been successfully validated using bacteriophage B14 capable of MRSA detection on SPR sensors, while MSSA strain did not bind to the device (Tawil et al. 2012) . Besides this remarkable performance, the authors described a LOD of 10 3 CFU per ml in PBS. More recently, the lytic phage 12600 has also been used for the detection of SA in complex samples such as food matrices (spinach leaves) (Byeon et al. 2015) , which confirms that bacteriophages may be employed in complex samples considered as more relevant than aqueous buffered solutions. In this example, the authors counted the number of bacteria eventually immobilized on small domains (2Á5 9 10 À5 m 2 ) of the magneto-elastic sensor. Unfortunately, this counting cannot easily be extrapolated to initial concentrations of SA in solution, and thus prevents the assessment of a LOD for this technique.
Besides whole bacteriophages, fragments of phage proteins can also be grafted on biosensing surfaces to ensure the specific capture of bacterial pathogens such as SA. The choice of molecular elements rather than wholephage particles is motivated by the limitations due to the handling, production and purification of bacteriophages. Eventually, the size of whole bacteriophage may also limit the sensitivity of detection methods such as SPR, by comparison with sensors functionalized with phage fragments. As an example, LysK, an endolysin produced by phages, efficiently recognizes SA and Staphylococcus saprophyticus but shows only little specificity on other staphylococci and no binding on Escherichia coli. This protein can be expressed and purified with standard techniques and eventually can be grafted on silicon surfaces for Staphylococcus detection (Chibli et al. 2014) . After SA cell labelling with DAPI, the specific capture of the targeted bacterium in PBS can be observed with a standard fluorescence microscope, with LOD around 5 9 10 3 CFU per ml. More recently, the same group described optical resonators functionalized with the LysK protein and enabling the label-free and real-time detection of SA (Ghali et al. 2016) . Although the sampling conditions (2 9 10 À6 l containing 10 7 bacteria) are still far from real SA contaminating levels, such example strengthens the possibility of decorating a large panel of sensors with phages for SA detection.
Aptamers
Aptamers are short nucleic acid sequences, originally made of RNA but more frequently made of DNA, exhibiting some affinity towards a predetermined target. Aptamers are isolated from large libraries of random nucleic acid sequences produced by solid-phase synthesis. The selection of DNA or RNA fragments displaying some affinity to a target is completed through a series of selecting/amplifying rounds named Systematic Evolution of Ligands by EXponential enrichment (SELEX) (Ellington and Szostak 1990; Tuerk and Gold 1990) . DNA or RNA aptamers can thus be selected against proteins, cells, bacteria, toxins or small molecules. Since the early 2000s, the number of biosensing devices involving aptamers as molecular probes has been regularly increasing. This is partly due to the several advantages of aptamers by comparison with antibodies. Aptamers are cheaper and easier to synthesize on larger scales than immunoglobulins; aptamers can be dried for storage and remain functional after subsequent solubilization; they might be selected against very small molecules (MW >1000 g mol À1 ) or toxins, which cannot be performed with antibodies. Thanks to solid-phase synthesis of nucleic acids, aptamers can be easily modified and tuned to dedicated applications by including labels, tags or any other chemical functionality required for further grafting on surfaces. SA has been chosen as a pathogen of interest in the selection of DNA aptamers (Cao et al. 2009; Chang et al. 2013; Moon et al. 2015) . Molecular components of the SA membrane, such as protein A, have thus also been used as targets in the search for DNA aptamers (Stoltenburg et al. 2015) along with clumping factor A, which turned out to yield very efficient SA-specific aptamers (Baumstummler et al. 2014) . In the search for aptamers binding whole SA cell, counterselection carried out with closely related species must be completed to ensure the highest specificity for the predetermined target. This critical point is often omitted or neglected by carrying out counterselection towards only poorly phylogenetically related bacteria such as E. coli or Salmonella (Moon et al. 2015) . Only few papers describe aptamer selection for whole SA cells and counterselection completed on more closely related strains such as Staphylococcus epidermidis (Cao et al. 2009; Chang et al. 2013 ). This latter SA-specific aptamer sequence identified by Chang et al. (2013) was grafted on gold nanoparticles and successfully used for SA optical detection by light scattering or fluorescence measurement (Zuo et al. 2013) . Model experiments involving aptamers as probes have also been completed on pig skin samples spiked with SA cells (5Á10 6 CFU/4 9 10 À4 m 2 ). The spiked skin was wiped with a swab, followed by PBS washes and incubation of the eluted solution on electrodes covered with carbon nanotubes functionalized with Cao's SA-specific aptamer (Zelada-Guillen et al. 2012) . In this example, as solid surfaces are covered by SA cells, contaminating levels are given as numbers of cells per unit area (rather than number of cells per volume). Although the SA recovery varied greatly depending on the assay (between 1Á6 and 29Á6% for five independent tests), such approach validated the SA direct detection on raw samples, making the protocol suitable for food industry facilities.
Peptides: a large repertoire of biomolecules for S. aureus detection
Antimicrobial peptides
Antimicrobial peptides (AMPs) are short (usually <50 amino acids long) natural peptides found in most living animals, both eukaryotic and prokaryotic organisms. They are involved in defence mechanisms against viruses, bacteria and fungi (Bahar and Ren 2013) . A general common feature of AMPs is their wide spectrum in terms of target neutralization (specific to Gram-negative, Grampositive or both, for instance). Interestingly, although they have strong affinity to bacterial membranes, their potential use as probes for biosensing applications is quite recent (Silva et al. 2014) . In the specific case of SA interactions with AMPs, it has been shown that this pathogen developed, during evolution, several mechanisms such as alteration of the overall negative charge of their membrane (thus decreasing the natural electrostatic interaction of most positively charged AMPs), or secretion of a cationic exopolysaccharide or proteases acting on AMPs (Joo and Otto 2015) . Although these unique characteristics may significantly affect the antibiotic action of AMPs on SA cells, AMPs can still be used as SA ligands in biosensing applications. Indeed, several examples of surface-immobilized AMPs used for SA detection have been described so far in the literature. For instance, in 2014, Kaur's group published two papers reporting the functionalization of gold-covered interdigitated electrodes with 39-amino acid-long leucocin A fragments for the impedimetric detection of pathogenic bacteria (Etayash et al. 2014; Azmi et al. 2015) . Although their devices reached remarkable LOD for the detection of Listeria monocytogenes by both full leucocin A peptide and a shorter leucocin A fragment, it turned out that such impedance-based measurement also enabled the detection of Enterococcus faecalis and SA in PBS, but to a much lesser extent. More recently, Liu et al. (2016) reported the use of cationic multidomain peptides with a general formula of K x (QL) y K z for the functionalization of gold-covered electrodes. The AMP-grafted devices (WK 3 (QL) 6 K 2 ) thus enabled the impedimetric detection of a large panel of either Gram-negative bacteria (E. coli and Pseudomonas aeruginosa) or Gram-positive bacteria (SA and S. epidermidis). As often in AMP-based detection, quantitative information must be taken with caution as most experiments lack any control led with non-AMPs, although such assay could strengthen the specificity of the detection. As a summary of this section, natural AMPs might be used as potential probes for SA biosensing applications although the universality of most AMPs towards a large panel of micro-organisms does not ensure their specificity to SA.
Peptides isolated from random libraries
Phage-displayed peptides offer the possibility to identify peptide sequences capable of selectivity towards SA. Such approach has been successfully used by Rao et al. (2013) who selected a 12-amino acid-long peptide with a remarkable selectivity towards SA and poor affinity to less relevant bacterial species such as Bacillus cereus, Klebsiella pneumoniae, P. aeruginosa, E. coli or S. epidermidis. Such characteristic was possible by running two counterselection cycles on the phage display peptide library. Then, the SA5-1 peptide sequence was conjugated to fluorescent quantum dots and used for SA detection after human platelet spiking, washing and detection monitoring by fluorometry. Control experiment led on a random peptide confirmed the effective selectivity of SA5-1 to SA.
Vancomycin
Vancomycin is an antibiotic of the glycopeptide family effective against Gram-positive bacteria. In particular, it is used against MRSA infections. According to Hiramatsu et al. (2014) , there are 6 9 10 6 possible binding sites for vancomycin in the peptidoglycan layer of each single SA cell. On the contrary, Gram-negative bacteria are naturally resistant to this antibiotic due to the position of the peptidoglycan layer located under the outer membrane which cannot be crossed by vancomycin. Therefore, vancomycin could be used as a specific probe for Gram-positive bacteria, including SA. Several papers show a great potential for bacteria concentration assessment and detection thanks to magnetic beads (Kell et al. 2008; Yang et al. 2015) or carbon dots (Zhong et al. 2015) functionalized with vancomycin. To gain specificity towards SA, Yang et al. (2015) used an alkaline phosphatase-tagged antibody, which binds to protein A and magnetic beads functionalized with vancomycin. Both the vancomycin and the antibody form a sandwich complex with SA, which can be monitored by the addition of the alkaline phosphatase substrate. SA concentrations ranging from 12 to 1Á2 9 10 6 CFU per ml are detected in 75 min. The technique also shows good specificity towards SA as three Gram-negative and three Gram-positive bacteria are tested as controls and revealed only weak signals. This assay has also been tested in real samples such as lake water, milk and human urine with SA recovery rates higher than 70% even at the lowest concentration of 1Á2 9 10 2 CFU per ml. In the same way, Gao et al. (2015) used both vancomycin and an antibody specific for SA in a sandwich-like assay. In this example, a polystyrene microplate is coated with the IgG. After incubation with SA suspension, vancomycin-tagged HRP molecules are added to the plate, and detection is performed with a protocol similar to standard ELISA.
Proteins
Lectins and sugar residues Similar to AMP or vancomycin, lectins can be used as broad-spectrum probes. Isolated from a wide range of biological materials, these proteins are able to selectively bind to oligosaccharide residues on the bacterial surface.
In their work, Gamella et al. (2009) showed that three bacteria (S. aureus, E. coli and Mycobacterium phlei) are distinguishable on the basis of their interactions with nine different lectins. However, each measure is performed separately as the sensing surface is functionalized with only one lectin. Yet, by measuring the b-galactosidase activity after binding of bacteria on the lectin concanavalin A (ConA), a more precise identification is reached with a clear distinction between SA and E. coli. Both bacteria have a similar affinity for ConA; however, only E. coli and other enterobacteria express b-galactosidase, the activity of which in the presence of its substrate is electrochemically detected.
Inversely, Adak et al. (2013) exploited the bacterial capacity to recognize and bind glycan present at the surface of their host cells to develop a sugar-based sensor (Fig. 2) . This ability, mediated by bacterial adhesins, contributes to bacterial pathogenicity. The trisaccharide (GalNAc(b1  4)Gal(b1  4)Glc) associated with BSA as a carrier protein is deposited onto a glass slide by inkjet printing. Analysis of the interaction pattern is then performed by optical darkfield microscopy. As for lectins, several bacterial species may to bind to this trisaccharide, which may lead to some cross-reactivity.
Immunoglobulins
In the field of biosensors, antibodies are widely used as probes in the so-called immunoassays (Byrne et al. 2009 ). Indeed, a large number of antibodies are commercially available and immunoglobulin G (IgG) immobilization techniques onto sensor surfaces are robust. However, as it has been highlighted in the first part of this review, SA detection with mammal immunoglobulins can be tricky due to the presence of protein A. One can argue that interactions between protein A and IgG are specific of SA and some papers previously cited exploit this reactivity as a positive response to SA detection Yang et al. 2015) . As schematized in Fig. 3a , Yan et al. used CH1 domain-specific scFv as a basal layer to bind rabbit IgG molecules in a controlled manner. Such fixed orientation thus enables the detection on quartz crystal microbalance (QCM) sensors of SA through protein A interaction with Fc (Fig. 3) . But such approach may be dependent on the presence of free IgG present in the sample. Indeed, a gain in sensitivity of a factor 5 to 6 is obtained when an acidic treatment of SA bacteria removes surface-bound IgG prior to QCM analysis (Yan et al. 2011) .
Protein A is not the only bacterial protein able to bind to the Fc region of antibodies as other bacterial proteins such as streptococcal protein G or M share this property. This entails a non-negligible risk of cross-reactivity of IgG with protein A and streptococcal proteins. Consequently, when trying to design a detection assay dedicated to several bacteria, antigen-antibody interactions are still more specific than those employing the Fc domain. Several strategies could solve this issue. Nonetheless, examples of whole IgG used for SA detection exist. Subramanian et al. (2005) detected SA in a direct assay by SPR with a sensitivity of 10 7 CFU per ml in PBS buffer with Tween-20. Rabbit anti-protein A antibodies are covalently bound to the biosensor surface through amine/ activated ester conjugation, implying that they are randomly oriented onto the surface. The specificity is checked with E. coli, but the reverse experiment with an antibody recognizing E. coli in the presence of SA is not presented. Besides, there is no control experiment with a nonspecific antibody which would assess the importance of protein A interactions with the Fc region. Similarly, in two papers (Tawil et al. 2013; Bandara et al. 2015) , the distinction between MSSA and MRSA strains thanks to an IgG recognizing PBP2a is presented. The authors used respectively SPR and optical fibre-based read-out as transducing techniques. But here again, protein A reactivity towards Fc domains is not taken into account and the control experiment with a nonspecific antibody is lacking. Such control is made in the work of Boujday et al. (2008) , where SA is detected using a QCM immunosensor. In this work, antibodies are fixed onto the surface previously coated with protein A, which guarantees both the correct IgG orientation, that is with the Fab domains facing the solution, and the inaccessibility of the IgG Fc domain for bacterial surface protein A recognition.
Another option for ensuring antigen-antibody interactions is to use chicken antibodies (IgY). Indeed, neither protein A nor protein G has affinity for bird immunoglobulins. IgY are bivalent immunoglobulins, as their mammal IgG homologs. They are slightly heavier than IgG, with a molecular weight of 180 000 g ml À1 against 150 000 g ml À1 for IgG. After chicken immunization consisting several injections of whole bacteria or purified bacterial proteins (Yamada et al. 2013; Walczak et al. 2015) , IgY are collected in hen eggs. One egg usually contains between 50 and 100 mg of antibodies, where 1-10% of them are specific of the antigen used for immunization. Yamada et al. (2013) developed an antiPBP2a IgY antibody and then used it in both ELISA and lateral-flow assay for the successful differentiation between MSSA and MRSA strains. This interesting approach proves that IgY could efficiently replace IgG for SA detection on immunoassays and thus eliminate high background level and risks of false-positive results due to protein A interactions with Fc. To avoid the repeated immunization and purification protocols of IgY, single-chain variable fragment (scFv) can be selected by phage display. scFv are constituted of one light and one heavy chain of antibody variable fragment. They are connected by a polypeptide linker and keep an active antigen-binding site. The phage display selection requires much work than simple immunization at the beginning, as DNA coding sequences from the fragment have to be collected from immune cells and then integrated in the phage genome. Li et al. (2016) produced a scFv derived from IgY antibodies, which possess antibacterial effect in vitro. Similarly, Nian et al. 
Enzymes
Enzymatic affinity for SA peptidoglycan has been exploited for the detection of this bacterium. Lysozyme, a 14 600 g mol À1 eukaryotic protein, exerts a catalytic activity on peptidoglycan mainly mediated by two amino acids, glutamate at position 35 and aspartate at position 52. The engineered mutation of the glutamate into an alanine results in a total loss of the catalytic activity without modification of the affinity for peptidoglycan. Lopes et al. (2016) used magnetic beads coated with this mutated lysozyme to capture SA from whole blood. Specific detection is then ensured by qPCR amplification of the 16S region of bacterial DNA. Although this method is sensitive and specific thanks to qPCR, it requires several steps for identification, thus increasing the costs and time to process. Ability to capture other Gram-positive bacteria including Enterococcus and Listeria is also demonstrated showing broad-range specificity. Yoon et al. (2013) used another enzyme, lysostaphin, only active against SA peptidoglycan cell wall. Their impedimetric sensor is functionalized with an antibody specific of SA peptidoglycan, and the lysostaphin activity results in a higher signal than with whole cells as peptidoglycan fragments interact more efficiently with the biosensing interface. Finally, after magnetic capture of SA cells in blood samples thanks to silica nanoparticles functionalized with Cao et al. (2009 ) aptamer. Borsa et al. (2016 increase the assay specificity by detecting the micrococcal nuclease activity specific of SA (Fig. 4) .
Conclusion
As a conclusion, S. aureus gathers a series of intrinsic molecular characteristics that make this bacterium quite unique in terms of difficulty for its fast and specific detection. Several strategies have been tested so far for the direct whole-cell detection, with very promising results obtained through ligand selections from random libraries, for instance (Table 2) . Aptamers, phage-displayed peptides or scFv engineered sequences turn out to be powerful ligands exhibiting a good selectivity to SA. A specific attention should be paid to counterselection protocols as too many papers describe biosensorbased SA detection without leading the most appropriate controls, that is assays led with random ligands and/or alternative bacterial strains. Bacteriophages as well appear as alternative natural binding elements suitable for surface immobilization and pathogen capture, although the production of large amounts of phage particles remains challenging. Eventually, ligands such as IgY proteins appear as very promising solutions for a selective detection of SA. For these reasons, along with the simultaneous increase in transducing performance of biosensors, the integration of microfluidics, and pointof-care devices, we are confident that the direct wholecell detection of bacteria on biosensors should remain a very active domain. Last but not least, the simultaneous assessment of antibiotics profiles with the identification of infectious pathogens is also a crucial issue for the physicians. Even though both analyses cannot be completed, so far, on a single device, we anticipate many efforts will be made in this direction in the near future. One promising route, although challenging and rarely used so far, could be based on the distinction of MRSA vs MSSA strains.
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